CorMedix Quote - CRMD

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

8.90

Bid

Offer

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

487.827M

Previous Close

8.90

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

54,812,000

Dividend Yield

PE Ratio

-12.42

Earnings Per Share (EPS)

-0.85

Revenue

Net Profit

-46.34M

Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the r... Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cormedix.com

Headquarters

Wilmington, Delaware, USA

Founded

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

BERKELEY HEIGHTS, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

PDUFA date remains February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients BERKELEY...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CRMD - Frequently Asked Questions (FAQ)

What is the current CorMedix share price?

The current share price of CorMedix is US$ 8.90

How many CorMedix shares are in issue?

CorMedix has 54,812,000 shares in issue

What is the market cap of CorMedix?

The market capitalisation of CorMedix is USD 487.83M

What is the 1 year trading range for CorMedix share price?

CorMedix has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of CorMedix?

The price to earnings ratio of CorMedix is -12.42

What is the reporting currency for CorMedix?

CorMedix reports financial results in USD

What is the latest annual profit for CorMedix?

The latest annual profit of CorMedix is USD -46.34M

What is the registered address of CorMedix?

The registered address for CorMedix is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the CorMedix website address?

The website address for CorMedix is www.cormedix.com

Which industry sector does CorMedix operate in?

CorMedix operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SIMGrupo Simec SAB de CV	US$ 41.85 (58.94%)	92
HNWPioneer Diversified High Income Fund Inc	US$ 18.99 (58.78%)	1
EPEmpire Petroleum Corporation	US$ 7.90 (33.22%)	14
LEUCentrus Energy Corporation	US$ 93.20 (13.92%)	6.47k
DCDakota Gold Corp	US$ 2.85 (13.55%)	16.95k
ATMPiPath Select MLP ETN	US$ 22.01 (-27.74%)	10
SVTServotronics Inc	US$ 8.01 (-26.48%)	1
LGLLGL Group Inc	US$ 5.01 (-25.89%)	2
AMBIAmbipar Emergency Response	US$ 4.11 (-22.01%)	1
INFUInfuSystems Holdings Inc	US$ 6.91 (-14.16%)	2
ETHU2x Ether ETF	US$ 4.68 (2.86%)	1.54M
FXIiShares China Large Cap	US$ 32.83 (1.70%)	1.45M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.81 (0.43%)	1.16M
KWEBKraneShares CSI China Internet	US$ 32.35 (1.70%)	852.57k
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.07 (0.33%)	829.79k